CAZypedia needs your help!
We have many unassigned pages in need of Authors and Responsible Curators. See a page that's out-of-date and just needs a touch-up? - You are also welcome to become a CAZypedian. Here's how.
Scientists at all career stages, including students, are welcome to contribute.
Learn more about CAZypedia's misson here and in this article.
Totally new to the CAZy classification? Read this first.
Difference between revisions of "Polysaccharide Lyase Family 8"
Harry Brumer (talk | contribs) m (Text replacement - "\^\^\^(.*)\^\^\^" to "$1") |
|||
(22 intermediate revisions by 3 users not shown) | |||
Line 2: | Line 2: | ||
<!-- RESPONSIBLE CURATORS: Please replace the {{UnderConstruction}} tag below with {{CuratorApproved}} when the page is ready for wider public consumption --> | <!-- RESPONSIBLE CURATORS: Please replace the {{UnderConstruction}} tag below with {{CuratorApproved}} when the page is ready for wider public consumption --> | ||
{{UnderConstruction}} | {{UnderConstruction}} | ||
− | * [[Author]]: | + | * [[Author]]: [[User:Michael Suits|Michael Suits]] |
− | * [[Responsible Curator]]: | + | * [[Responsible Curator]]: [[User:Michael Suits|Michael Suits]] |
---- | ---- | ||
Line 12: | Line 12: | ||
|{{Hl2}} colspan="2" align="center" |'''Polysaccharide Lyase Family PL8''' | |{{Hl2}} colspan="2" align="center" |'''Polysaccharide Lyase Family PL8''' | ||
|- | |- | ||
− | | | + | |'''3D Structure''' |
− | |(alpha/alpha)6 barrel + anti-parallel beta-sheet | + | |(α/α)<sub>6</sub> barrel + anti-parallel β-sheet |
|- | |- | ||
|'''Mechanism''' | |'''Mechanism''' | ||
− | |beta-elimination | + | |β-elimination |
+ | |- | ||
+ | |'''Charge neutraliser''' | ||
+ | |His399 (''S. pneumoniae'') | ||
|- | |- | ||
|'''Active site residues''' | |'''Active site residues''' | ||
− | | | + | |Known |
|- | |- | ||
|{{Hl2}} colspan="2" align="center" |'''CAZy DB link''' | |{{Hl2}} colspan="2" align="center" |'''CAZy DB link''' | ||
Line 29: | Line 32: | ||
− | == Substrate | + | == Activities and Substrate Specificities == |
− | + | PL8s are active on a variety of uronic acid-containing polysaccharides including: hyaluronan (EC 4.2.2.1) [4)-β-D-Glucuronate-1,3-β-D-N-Acetyl-Glucosamine(1]<sub>n</sub>, chondroitin AC (EC 4.2.2.5) [4)-β-D-Glucuronate-1,3-β-D-N-Acetyl-GalactosamineΔ4,6S(1]<sub>n</sub>, xanthan (EC 4.2.2.12) [4)-β-D-Glucuronate-1,4-β-D-Glucuronate (1]<sub>n</sub>, and chondroitin ABC (EC 4.2.2.20) [chondroitin AC and chondroitin B (aka. dermatan sulfate: 4)-β-L-Iduronate2S-1,3-β-D-N-Acetyl-Galactosamine4S(1]<sub>n</sub>. | |
− | + | == Kinetics and Mechanism == | |
+ | One of the major unresolved controversies around the PL8 catalytic mechanism is the candidate of the general base. Jedrzejas ''et al''. proposed that in the ''Streptococcus pneumoniae'' hyaluronidase, His399 acts as the general base, Asn349 acts to neutralize the C5-carboxylate group, and Tyr408 is the proton donor <cite>Kelly2001, Li2000</cite>. However, for two other PL8 family members: the ''Bacillus'' sp. GL1 xanthanase and ''Streptomyces coelicolor'' A3 hyaluronidase, it was suggested that an equivalent tyrosine residue served as the general acid and general base throughout the reaction <cite>Maruyama2005, Elmabrouk2011</cite>. Combined quantum mechanical and molecular mechanical (QM/MM) simulations of the ''S. pneumoniae'' enzyme suggests the latter hypothesis is favored, with His399 participating in the neutralization of the C5-carboxylate group <cite>Zheng2013</cite>. Molecular dynamic simulations of the pneumococcal hyaluronidase with hyaluronan fragments suggest that a combination of opening/closing and twisting domain motions of the (α/α)<sub>6</sub> barrel with respect to the anti-parallel β-sheet domain underlies processive substrate translocation <cite>Joshi2009</cite>. | ||
− | In the | + | == Catalytic Residues == |
+ | In ''S. pneumoniae'', mutagenesis and kinetic analysis of the HysA mutant suggested three residues were involved in catalysis Asn249, His399, Tyr408 and that two residues, Arg243 and Asn580 were responsible for substrate binding and translocation <cite>Kelly2001</cite>. However, there is some question over what the identity is over the general base (please see Elmabrouk or Zheng ''et al''. for discussions <cite>Elmabrouk2011, Zheng2013</cite>. With respect to chondroitin AC and chondroitin ABC substrate specificity; structural comparisons of the ''Flavobacterium heparinum'' chondroitin AC lyase with the ''Proteus vulgaris'' chondroitin ABC lyase suggests that an Asp444 for an Asn differential in the ''Proteus vulgaris'' active centre provides the mechanism for enzymatic distinguishing between the two epimers <cite>Fethiere1999, Huang2003</cite>. | ||
− | == | + | == Three dimensional structure == |
− | + | The enzymatic PL8 domain is comprised by an N-terminal α-helical and C-terminal β-sheet domain, which constitute incomplete α<sub>5</sub>/α<sub>5</sub>-barrel and anti-parallel β-sheet structures, respectively. A deep cleft is located in the N-terminal α-helical domain facing the interface between the two domains that accommodates the substrate. | |
− | + | '''Three dimensional structures by activity''':<br/> | |
− | + | Chondroitin AC lyase (EC 4.2.2.5) - ''F. heparinum'' <cite>Fethiere1999</cite>([{{PDBlink}}1cb8 PDB 1CB8]).<br/> | |
+ | Chondroitin ABC lyase (EC 4.2.2.20) – ''P. vulgaris'' <cite>Huang2003</cite>([{{PDBlink}}1hn0 PDB 1HN0]).<br/> | ||
+ | Hyaluronan lyase (EC 4.2.2.1) – ''S. pneumoniae'' R6 <cite>Li2000</cite>([{{PDBlink}}1ojm PDB 1OJM]).<br/> | ||
+ | Xanthan lyase (EC 4.2.2.12) – ''Bacillus'' sp GL1 <cite>Hashimoto2003</cite>([{{PDBlink}}1j0m PDB 1J0M]).<br/> | ||
− | |||
− | |||
== Family Firsts == | == Family Firsts == | ||
− | ;First | + | ;First catalytic activity: The hydrolysis of hyaluronan was attributed to a pneumococcal hyaluronidase from Pneumococcus type II strain D39R <cite>Rapport1951</cite>. |
− | ;First catalytic | + | ;First catalytic base correctly identified: Xanthanase Y315 from 'Bacillus'' sp. GL1 <cite>Maruyama2005</cite>. |
− | + | ;First 3-D structure: Chondroitin AC lyase – ''F. heparinum'' <cite>Fethiere1999</cite>([{{PDBlink}}1cb8 PDB 1CB8]). | |
− | ;First 3-D structure: | + | |
== References == | == References == | ||
<biblio> | <biblio> | ||
− | # | + | |
− | # | + | #Rapport1951 pmid=14917676 |
+ | #Li2000 pmid=10716923 | ||
+ | #Fethiere1999 pmid=10329169 | ||
+ | #Sato1994 pmid=7512814 | ||
+ | #Huang2003 pmid=12706721 | ||
+ | #Hashimoto1998 pmid=9758797 | ||
+ | #Hashimoto2003 pmid=16348550 | ||
+ | #Maruyama2005 pmid=15979090 | ||
+ | #Kelly2001 pmid=11358878 | ||
+ | #Elmabrouk2011 pmid=21287626 | ||
+ | #Zheng2013 pmid=23944739 | ||
+ | #Joshi2009 pmid=19089975 | ||
+ | |||
</biblio> | </biblio> | ||
[[Category:Polysaccharide Lyase Families|PL008]] | [[Category:Polysaccharide Lyase Families|PL008]] |
Latest revision as of 13:18, 18 December 2021
This page is currently under construction. This means that the Responsible Curator has deemed that the page's content is not quite up to CAZypedia's standards for full public consumption. All information should be considered to be under revision and may be subject to major changes.
Polysaccharide Lyase Family PL8 | |
3D Structure | (α/α)6 barrel + anti-parallel β-sheet |
Mechanism | β-elimination |
Charge neutraliser | His399 (S. pneumoniae) |
Active site residues | Known |
CAZy DB link | |
https://www.cazy.org/PL8.html |
Activities and Substrate Specificities
PL8s are active on a variety of uronic acid-containing polysaccharides including: hyaluronan (EC 4.2.2.1) [4)-β-D-Glucuronate-1,3-β-D-N-Acetyl-Glucosamine(1]n, chondroitin AC (EC 4.2.2.5) [4)-β-D-Glucuronate-1,3-β-D-N-Acetyl-GalactosamineΔ4,6S(1]n, xanthan (EC 4.2.2.12) [4)-β-D-Glucuronate-1,4-β-D-Glucuronate (1]n, and chondroitin ABC (EC 4.2.2.20) [chondroitin AC and chondroitin B (aka. dermatan sulfate: 4)-β-L-Iduronate2S-1,3-β-D-N-Acetyl-Galactosamine4S(1]n.
Kinetics and Mechanism
One of the major unresolved controversies around the PL8 catalytic mechanism is the candidate of the general base. Jedrzejas et al. proposed that in the Streptococcus pneumoniae hyaluronidase, His399 acts as the general base, Asn349 acts to neutralize the C5-carboxylate group, and Tyr408 is the proton donor [1, 2]. However, for two other PL8 family members: the Bacillus sp. GL1 xanthanase and Streptomyces coelicolor A3 hyaluronidase, it was suggested that an equivalent tyrosine residue served as the general acid and general base throughout the reaction [3, 4]. Combined quantum mechanical and molecular mechanical (QM/MM) simulations of the S. pneumoniae enzyme suggests the latter hypothesis is favored, with His399 participating in the neutralization of the C5-carboxylate group [5]. Molecular dynamic simulations of the pneumococcal hyaluronidase with hyaluronan fragments suggest that a combination of opening/closing and twisting domain motions of the (α/α)6 barrel with respect to the anti-parallel β-sheet domain underlies processive substrate translocation [6].
Catalytic Residues
In S. pneumoniae, mutagenesis and kinetic analysis of the HysA mutant suggested three residues were involved in catalysis Asn249, His399, Tyr408 and that two residues, Arg243 and Asn580 were responsible for substrate binding and translocation [1]. However, there is some question over what the identity is over the general base (please see Elmabrouk or Zheng et al. for discussions [4, 5]. With respect to chondroitin AC and chondroitin ABC substrate specificity; structural comparisons of the Flavobacterium heparinum chondroitin AC lyase with the Proteus vulgaris chondroitin ABC lyase suggests that an Asp444 for an Asn differential in the Proteus vulgaris active centre provides the mechanism for enzymatic distinguishing between the two epimers [7, 8].
Three dimensional structure
The enzymatic PL8 domain is comprised by an N-terminal α-helical and C-terminal β-sheet domain, which constitute incomplete α5/α5-barrel and anti-parallel β-sheet structures, respectively. A deep cleft is located in the N-terminal α-helical domain facing the interface between the two domains that accommodates the substrate.
Three dimensional structures by activity:
Chondroitin AC lyase (EC 4.2.2.5) - F. heparinum [7](PDB 1CB8).
Chondroitin ABC lyase (EC 4.2.2.20) – P. vulgaris [8](PDB 1HN0).
Hyaluronan lyase (EC 4.2.2.1) – S. pneumoniae R6 [2](PDB 1OJM).
Xanthan lyase (EC 4.2.2.12) – Bacillus sp GL1 [9](PDB 1J0M).
Family Firsts
- First catalytic activity
- The hydrolysis of hyaluronan was attributed to a pneumococcal hyaluronidase from Pneumococcus type II strain D39R [10].
- First catalytic base correctly identified
- Xanthanase Y315 from 'Bacillus sp. GL1 [3].
- First 3-D structure
- Chondroitin AC lyase – F. heparinum [7](PDB 1CB8).
References
- Kelly SJ, Taylor KB, Li S, and Jedrzejas MJ. (2001). Kinetic properties of Streptococcus pneumoniae hyaluronate lyase. Glycobiology. 2001;11(4):297-304. DOI:10.1093/glycob/11.4.297 |
- Li S, Kelly SJ, Lamani E, Ferraroni M, and Jedrzejas MJ. (2000). Structural basis of hyaluronan degradation by Streptococcus pneumoniae hyaluronate lyase. EMBO J. 2000;19(6):1228-40. DOI:10.1093/emboj/19.6.1228 |
- Maruyama Y, Hashimoto W, Mikami B, and Murata K. (2005). Crystal structure of Bacillus sp. GL1 xanthan lyase complexed with a substrate: insights into the enzyme reaction mechanism. J Mol Biol. 2005;350(5):974-86. DOI:10.1016/j.jmb.2005.05.055 |
- Elmabrouk ZH, Vincent F, Zhang M, Smith NL, Turkenburg JP, Charnock SJ, Black GW, and Taylor EJ. (2011). Crystal structures of a family 8 polysaccharide lyase reveal open and highly occluded substrate-binding cleft conformations. Proteins. 2011;79(3):965-74. DOI:10.1002/prot.22938 |
- Zheng M and Xu D. (2013). Catalytic mechanism of hyaluronate lyase from Streptococcus pneumonia [corrected] : quantum mechanical/molecular mechanical and density functional theory studies. J Phys Chem B. 2013;117(35):10161-72. DOI:10.1021/jp406206s |
- Joshi HV, Jedrzejas MJ, and de Groot BL. (2009). Domain motions of hyaluronan lyase underlying processive hyaluronan translocation. Proteins. 2009;76(1):30-46. DOI:10.1002/prot.22316 |
- Féthière J, Eggimann B, and Cygler M. (1999). Crystal structure of chondroitin AC lyase, a representative of a family of glycosaminoglycan degrading enzymes. J Mol Biol. 1999;288(4):635-47. DOI:10.1006/jmbi.1999.2698 |
- Huang W, Lunin VV, Li Y, Suzuki S, Sugiura N, Miyazono H, and Cygler M. (2003). Crystal structure of Proteus vulgaris chondroitin sulfate ABC lyase I at 1.9A resolution. J Mol Biol. 2003;328(3):623-34. DOI:10.1016/s0022-2836(03)00345-0 |
- Ahlgren JA (1991). Purification and characterization of a pyruvated-mannose-specific xanthan lyase from heat-stable, salt-tolerant bacteria. Appl Environ Microbiol. 1991;57(9):2523-8. DOI:10.1128/aem.57.9.2523-2528.1991 |
- RAPPORT MM, LINKER A, and MEYER K. (1951). The hydrolysis of hyaluronic acid by pneumococcal hyaluronidase. J Biol Chem. 1951;192(1):283-91. | Google Books | Open Library
- Sato N, Shimada M, Nakajima H, Oda H, and Kimura S. (1994). Cloning and expression in Escherichia coli of the gene encoding the Proteus vulgaris chondroitin ABC lyase. Appl Microbiol Biotechnol. 1994;41(1):39-46. DOI:10.1007/BF00166079 |
- Hashimoto W, Miki H, Tsuchiya N, Nankai H, and Murata K. (1998). Xanthan lyase of Bacillus sp. strain GL1 liberates pyruvylated mannose from xanthan side chains. Appl Environ Microbiol. 1998;64(10):3765-8. DOI:10.1128/AEM.64.10.3765-3768.1998 |